Overview
Connections
News
Salaries
Products
People
Growth
Offices
Financials

Visa sponsorship

A-rated
Sponsor licence
Skilled Worker +1
Visa route
0
Open roles in United Kingdom
In the register as Congenica LTD, Cambridge
Other sponsors in the same field
Alert me
UK Home Office · checked Nov 3, 2026 · Visa details by country

Overview

Congenica is a Cambridge company founded in 2014 that interprets genomic data for clinical diagnosis. Its software analyses whole genome sequences to identify disease causing variants and was adopted by the British hundred thousand genomes programme. The company works with health systems and pharmaceutical partners internationally.

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors2
CICVia a fund
31 portfolio companies: Pragmatic Semiconductor, CMR Surgical, Abcodia and 28 more
151 portfolio companies: Zetta Genomics, Zentraxa Seed, Zomp and 148 more

News

News YahooFinance 4 years ago
Congenica Appoints Dr. Tom Barber as Chief Scientific Officer
Congenica Appoints Dr. Tom Barber as Chief Scientific Officer Cambridge, United Kingdom - 3rd May 2022 - Congenica, a digital health company that enables precision medicine through its world-leading diagnostic decision support platform for genomic data, a
Read more
Report
Congenica completes $50m series C funding round
Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people's lives, is pleased to announce the completion of its Series C funding round,…
Read more
Report
News PE Hub 9 years ago
Congenica closes B round
Congenica said April 27 that it closed a Series B round of funding. Additional investors include BGI Genomics, Healthlink Capital and Future Planet Capital. Congenica, of Cambridge, U.K., is a developer of clinical genomics software for inherited diseases
Read more
Report
News seqone.com
SeqOne Genomics appoints Martin Dubuc as Chief Executive Officer
Martin Dubuc appointed as SeqOne Genomics CEO, Nicolas Philippe becomes President & CPSO to drive global clinical genomics expansion.
Read more
Report
News seqone.com
Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancer
The PAOLA-1/ENGOT-ov25 trial showed that maintenance olaparib plus bevacizumab increases survival of advanced ovarian cancer patients with homologous recombination deficiency (HRD).
Read more
Report
News seqone.com
SeqOne acquires Congenica to create a global leader in AI-powered genomic medicine
Strategic acquisition of UK genomics leader Congenica reinforces SeqOne market position and footprint - servicing over 160 labs in 30+ countries.
Read more
Report

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Cambridge United Kingdom
HQ
10-50 est. staff

Financials

Total raised
$51.3M
Latest round
Venture - Series Unknown
Funding rounds
19
Funding rounds
Round Announced Amount
Venture - Series Unknown 2024 — Details
Venture - Series Unknown 2023 — Details
Venture - Series Unknown 2023 — Details
Venture - Series Unknown 2022 — Details
Grant 2021 $806k Details
Venture - Series Unknown 2021 — Details
Series C 2020 $50M Details
Venture - Series Unknown 2020 — Details
Venture - Series Unknown 2019 — Details
Venture - Series Unknown 2019 — Details
Venture - Series Unknown 2018 — Details
Grant 2018 $517k Details
Venture - Series Unknown 2018 — Details
Venture - Series Unknown 2017 — Details
Series B 2017 — Details
Venture - Series Unknown 2017 — Details
Venture - Series Unknown 2015 — Details
Venture - Series Unknown 2015 — Details
Venture - Series Unknown 2014 — Details